Medtronic plc (NYSE:MDT)

Medtronic is the world’s leading medical technology company, pioneering device-based therapies that restore health, extend life and alleviate pain. Primary products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, among others. Medtronic operates its business in one reportable segment, that of manufacturing and selling device-based medical therapies. The company does business in more than 120 countries. The company’s product lines include cardiac rhythm management, neurological and spinal, vascular and cardiac surgery.

Medtronic plc (NYSE:MDT)’s Financial Overview

Medtronic plc (NYSE:MDT) declined -0.77% yesterday to close its trading session at $73.42. The company has 1 year Price Target of $92. Medtronic plc has 52-Week high of $89.27 and 52-Week Low of $71.03. The stock touched its 52-Week High on Jul 15, 2016 and 52-Week Low on Feb 9, 2016. The stock traded with the volume of 6.75 Million shares yesterday. The firm shows the market capitalization of $101.46 Billion.

Medtronic plc (NYSE:MDT) reported its last quarterly earnings on Oct 16 where the firm reported its Actual EPS of $1.12/share against the analyst consensus estimate of $1.11/share. The difference between the actual and expected EPS is $0.01 a share with a surprise factor of 0.9%.

The firm is trading with SMA20 of -8.56 Percent, SMA50 of -11.54 Percent and SMA200 of -10.52 percent. Medtronic plc has P/S value of 3.53 while its P/B value stands at 2.02. Similarly, the company has Return on Assets of 0 percent, Return on Equity of 0 percent and Return on Investment of 5.4 Percent. The company shows Gross Margin and Operating Margin of 68.9 percent and 0 percent respectively.

Many brokerage firms are involved in issuing their ratings on Medtronic plc (NYSE:MDT). On 23-Aug-16 Citigroup Initiated Medtronic plc Stock  to Buy. Another firm also rated the stock on 9-Jun-16 where Guggenheim Initiated the stock to Neutral.

The Stock currently has Analyst’ mean Recommendation of 2 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 20 analysts offering 12-month price forecasts for Medtronic PLC have a median target of 94.00, with a high estimate of 104.00 and a low estimate of 83.00. The median estimate represents a +28.03% increase from the last price of 73.42.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Avon Products Inc. (NYSE:AVP)

Avon Products, Inc. is one of the world’s leading manufacturers and marketers of beauty and related products, which include cosmetics, fragrance and toiletries; beauty plus which consists of jewelry and accessories and apparel; and non-core which consists of gift and decorative and home entertainment products.

Avon Products Inc. (NYSE:AVP)’s Financial Outlook

The 13 analysts offering 12-month price forecasts for Avon Products Inc have a median target of 6.50, with a high estimate of 8.00 and a low estimate of 4.00. The median estimate represents a +19.05% increase from the last price of 5.46.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, Avon Products Inc. has a Consensus Recommendation of 2.5. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock fell -1.97% and closed its last trading session at $5.46. The company has the market capitalization of $2.39 Billion. The stock has 52-week high of $6.96 and 52-Week low of $2.21. The firm touched its 52-Week high on Oct 25, 2016 and 52-Week low on Jan 20, 2016. The company has volume of 6.74 Million shares. The company has a total of 437.52 Million shares outstanding.

Avon Products Inc. (NYSE:AVP) in the last quarter reported its actual EPS of $0.02/share where the analyst estimated EPS was $0.03/share. The difference between the actual and Estimated EPS is $-0.01. This shows a surprise factor of -33.3 percent.

The company has YTD performance of 34.81 percent. Beta for Avon Products Inc. stands at 2.04 while its ATR (average true range) is 0.25. The company has Weekly Volatility of 3.62%% and Monthly Volatility of 4.65%%.

Avon Products Inc. has distance from 20-day Simple Moving Average (SMA20) of -6.19%, Distance from 50-Day Simple Moving Average of -8.79 percent and Distance from 200-Day Simple Moving Average of 12.61%.

The Company currently has ROA (Return on Assets) of -11.7 percent, Return on Equity (ROE) of 49.1 Percent and Return on Investment (ROI) of -58.1% with Gross margin of 60.1 percent and Operating & Profit margin of 6.1% and -8.7% respectively.